Bone Drugs Pose No Clear Threat To Heart: FDA
The U.S. Food and Drug Administration has announced that there appears to be no significant connection between the class of bone disease medications known as bisphosphonates and an increased risk of...To view the full article, register now.
Already a subscriber? Click here to view full article